{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:49:26Z","timestamp":1791892166073,"version":"4.3.4"},"reference-count":48,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100007366","name":"Fondazione Italiana Sclerosi Multipla","doi-asserted-by":"publisher","award":["2022\/PR-Single\/016"],"award-info":[{"award-number":["2022\/PR-Single\/016"]}],"id":[{"id":"10.13039\/100007366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["DIGITAL HEALTH"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Telerehabilitation may overcome accessibility barriers related to the Lee Silverman Voice Treatment (LSVT)-Loud for dysphonia rehabilitation in multiple sclerosis (MS). The present study provides the feasibility evidence on patient-relevant structural and procedure effects of a pilot randomized controlled trial comparing LSVT-Loud telerehabilitation (Tele-LSVT-Loud) versus standard delivery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Twenty-one people with MS (six males) with dysphonia were 1:1 randomly allocated to 4 weeks of LSVT-Loud in-site or Tele-LSVT-Loud at home accessing a telemedicine platform. The feasibility of Tele-LSVT-Loud compared to LSVT-Loud was evaluated considering adherence rate, safety (adverse events), technology interaction (User Experience Questionnaire), intrinsic motivation to the treatment (Intrinsic Motivation Inventory), and perceived rehabilitation experience (individual qualitative interviews) during and after the intervention program.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Thirty-one percent of eligible subjects were unavailable to follow in-site treatment. Drops-outs were higher in the LSVT-Loud than Tele-LSVT-Loud group (4 versus 1). Also, the adherence rate of synchronous sessions was 68.75% in the LSVT-Loud compared to 87.5% in the Tele-LSVT-Loud group, related to greater difficulty in integrating the treatment into a daily routine, as mentioned in the qualitative interview. No relevant adverse events were observed in both groups. The user experience with technology in the Tele-LSVT-Loud group was positive. The interviews revealed a positive therapeutic alliance, regardless of the delivery path. Interestingly, only people in the Tele-LSVT-Loud group judged equivalent the therapist-user relationship in in-site and telerehabilitation settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Telerehabilitation promotes the feasibility of LSVT-Loud. The modality of delivery is a relevant factor in determining eligibility and adherence to a voice rehabilitation program in MS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/20552076251326222","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T02:01:06Z","timestamp":1748224866000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Delivering the Lee Silverman voice treatment-loud method in-site versus telerehabilitation in people with multiple sclerosis: Feasibility evidence of a non-inferiority pilot randomized controlled trial"],"prefix":"10.1177","volume":"11","author":[{"given":"Chiara","family":"Vitali","sequence":"first","affiliation":[{"name":"IRCCS Fondazione Don Carlo Gnocchi ONLUS, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Fusari","sequence":"additional","affiliation":[{"name":"IRCCS Fondazione Don Carlo Gnocchi ONLUS, Milan, Italy"},{"name":"Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego Michael","family":"Cacciatore","sequence":"additional","affiliation":[{"name":"IRCCS Fondazione Don Carlo Gnocchi ONLUS, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Smecca","sequence":"additional","affiliation":[{"name":"IRCCS Fondazione Don Carlo Gnocchi ONLUS, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Baldanzi","sequence":"additional","affiliation":[{"name":"IRCCS Fondazione Don Carlo Gnocchi ONLUS, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Carullo","sequence":"additional","affiliation":[{"name":"Department of Electronics and Telecommunications, Politecnico of Turin, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Rovaris","sequence":"additional","affiliation":[{"name":"IRCCS Fondazione Don Carlo Gnocchi ONLUS, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Cattaneo","sequence":"additional","affiliation":[{"name":"IRCCS Fondazione Don Carlo Gnocchi ONLUS, Milan, Italy"},{"name":"Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Baglio","sequence":"additional","affiliation":[{"name":"IRCCS Fondazione Don Carlo Gnocchi ONLUS, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0849-3984","authenticated-orcid":false,"given":"Sara","family":"Isernia","sequence":"additional","affiliation":[{"name":"IRCCS Fondazione Don Carlo Gnocchi ONLUS, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,5,25]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1177\/22799036231222115"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.2196\/25675"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01473-3"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1159\/000266286"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvoice.2003.05.004"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1080\/17549507.2023.2180094"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2018.06.010"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-023-01230-3"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-009-0170-3"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1044\/jslhr.4005.1056"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1177\/1545968306294737"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1177\/13524585211051059"},{"key":"e_1_3_3_14_2","first-page":"111","article-title":"Current perspectives on the Lee Silverman Voice Treatment (LSVT) for individuals with idiopathic Parkinson disease","author":"Fox CM","unstructured":"Fox CM, Morrison CE, Ramig LO, et al. Current perspectives on the Lee Silverman Voice Treatment (LSVT) for individuals with idiopathic Parkinson disease. Am J Speech Lang Pathol 2002; 11: 111\u2013123.","journal-title":"Am J Speech Lang Pathol"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.47.6.1496"},{"key":"e_1_3_3_16_2","first-page":"141","article-title":"Effects of intensive phonatory-respiratory treatment (LSVT\u00ae) on voice in individuals with multiple sclerosis","volume":"14","author":"Sapir S","year":"1999","unstructured":"Sapir S, PawJas A, Ramig L, et al. Effects of intensive phonatory-respiratory treatment (LSVT\u00ae) on voice in individuals with multiple sclerosis. NCVS Status Progress Rep 1999; 14: 141\u2013147.","journal-title":"NCVS Status Progress Rep"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvoice.2020.07.025"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.7224\/1537-2073.2021-056"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1177\/20552076231218150"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30470-2"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.33.11.1444"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-014-1921-3"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/18.Supplement_1.S79"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1177\/20552076241228928"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1044\/1058-0360.0603.66"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1080\/09638288.2016.1223177"},{"key":"e_1_3_3_27_2","first-page":"40","article-title":"Construction of a benchmark for the user experience questionnaire (UEQ)","volume":"4","author":"Schrepp M","year":"2017","unstructured":"Schrepp M, Hinderks A, Thomaschewski J. Construction of a benchmark for the user experience questionnaire (UEQ). Int J Interact Multim Artif Intell 2017; 4: 40\u201344.","journal-title":"Int J Interact Multim Artif Intell"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1080\/02701367.1989.10607413"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1177\/1357633X19850381"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1177\/1357633X211054839"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.01206"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.5195\/ijt.2018.6258"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.3109\/17549507.2012.686119"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.3109\/17549507.2012.700323"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.7224\/1537-2073.2022-002"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-021-05398-6"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2017.05.011"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.2196\/mental.5710"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1080\/10749357.2019.1683792"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1080\/09638288.2022.2055159"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.2340\/16501977-2277"},{"key":"e_1_3_3_42_2","article-title":"Exercise therapy for fatigue in multiple sclerosis","volume":"2015","author":"Heine M","year":"2015","unstructured":"Heine M, van de Port I, Rietberg MB, et al. Exercise therapy for fatigue in multiple sclerosis. Cochrane Database Syst Rev 2015; 2015: Cd009956.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_3_43_2","article-title":"Lee Silverman voice treatment versus NHS speech and language therapy versus control for dysarthria in people with Parkinson's disease (PD COMM): pragmatic, UK based, multicentre, three arm, parallel group, unblinded, randomised controlled trial","volume":"386","author":"Sackley CM","year":"2024","unstructured":"Sackley CM, Rick C, Brady MC, et al. Lee Silverman voice treatment versus NHS speech and language therapy versus control for dysarthria in people with Parkinson's disease (PD COMM): pragmatic, UK based, multicentre, three arm, parallel group, unblinded, randomised controlled trial. Br Med J 2024; 386: e078341.","journal-title":"Br Med J"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2024.108162"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1258\/jtt.2007.007040"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1154481"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.2519\/jospt.2022.11152"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1080\/17549507.2017.1292547"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1258\/jtt.2010.100318"}],"container-title":["DIGITAL HEALTH"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20552076251326222","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/20552076251326222","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20552076251326222","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T17:51:32Z","timestamp":1777398692000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/20552076251326222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":48,"alternative-id":["10.1177\/20552076251326222"],"URL":"https:\/\/doi.org\/10.1177\/20552076251326222","relation":{},"ISSN":["2055-2076","2055-2076"],"issn-type":[{"value":"2055-2076","type":"print"},{"value":"2055-2076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5]]},"article-number":"20552076251326222"}}